• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor.

作者信息

Chan Karmela Kim, Bass Anne R

机构信息

Department of Medicine, Division of Rheumatology, Hospital for Special Surgery, New York, New York, USA.

出版信息

Ann Rheum Dis. 2019 Jul;78(7):e70. doi: 10.1136/annrheumdis-2018-213672. Epub 2018 May 14.

DOI:10.1136/annrheumdis-2018-213672
PMID:29760158
Abstract
摘要

相似文献

1
Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor.由MEK 1/2抑制剂考比替尼控制的检查点抑制剂诱导的多肌痛风湿症。
Ann Rheum Dis. 2019 Jul;78(7):e70. doi: 10.1136/annrheumdis-2018-213672. Epub 2018 May 14.
2
Response to: 'Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor' by Chan and Bass.对Chan和Bass所著的《由MEK 1/2抑制剂考比替尼控制的检查点抑制剂诱导的风湿性多肌痛》的回应
Ann Rheum Dis. 2019 Jul;78(7):e71. doi: 10.1136/annrheumdis-2018-213682. Epub 2018 Jun 20.
3
Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis.风湿性多肌痛和巨细胞动脉炎患者的组织细胞因子模式。
Ann Intern Med. 1994 Oct 1;121(7):484-91. doi: 10.7326/0003-4819-121-7-199410010-00003.
4
Management of immune checkpoint inhibitor-induced polymyalgia rheumatica.免疫检查点抑制剂诱导的风湿性多肌痛的管理。
Ann Rheum Dis. 2022 Dec;81(12):e263. doi: 10.1136/annrheumdis-2020-218276. Epub 2020 Sep 4.
5
Serum immunoglobulin G4 in giant cell arteritis and polymyalgia rheumatica.巨细胞动脉炎和风湿性多肌痛中的血清免疫球蛋白G4
Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):94-97. Epub 2016 Dec 2.
6
Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis.风湿性多肌痛和巨细胞动脉炎患者体内抗心磷脂抗体和抗β2糖蛋白I抗体
Rev Rhum Engl Ed. 1996 Apr;63(4):241-7.
7
[Polymyalgia rheumatica and temporal arteritis. New aspects of diagnosis, treatment, prognosis and risk of cancer].[风湿性多肌痛和颞动脉炎。诊断、治疗、预后及癌症风险的新进展]
Tidsskr Nor Laegeforen. 1994 Sep 30;114(23):2716-8.
8
Polymyalgia rheumatica and temporal arteritis in blacks--clinical features and HLA typing.黑人的风湿性多肌痛和颞动脉炎——临床特征与HLA分型
J Rheumatol. 1977 Winter;4(4):435-42.
9
HLA antigens in patients with giant cell arteritis and polymyalgia rheumatica.巨细胞动脉炎和风湿性多肌痛患者的人类白细胞抗原（HLA）抗原
J Rheumatol. 1977 Autumn;4(3):321-3.
10
Imaging in immune checkpoint inhibitor-induced polymyalgia rheumatica.免疫检查点抑制剂诱发的风湿性多肌痛的影像学表现
Ann Rheum Dis. 2022 Oct;81(10):e210. doi: 10.1136/annrheumdis-2020-217381. Epub 2020 Apr 2.

引用本文的文献

1
Immune checkpoint inhibitor associated vasculitis and polymyalgia rheumatica: a case series and systematic review.免疫检查点抑制剂相关血管炎和风湿性多肌痛：病例系列及系统评价
BMC Rheumatol. 2025 Oct 1;9(1):111. doi: 10.1186/s41927-025-00528-5.
2
Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas Emerging from a Systematic Review of Published Literature.免疫检查点抑制剂（ICI）治疗后风湿性多肌痛（PMR）及类PMR综合征的识别与分类：基于已发表文献系统评价所产生的讨论要点及灰色地带
Medicines (Basel). 2020 Nov 3;7(11):68. doi: 10.3390/medicines7110068.
3
Arthralgia Induced by BRAF Inhibitor Therapy in Melanoma Patients.
黑色素瘤患者BRAF抑制剂治疗引起的关节痛
Cancers (Basel). 2020 Oct 16;12(10):3004. doi: 10.3390/cancers12103004.
4
Polymyalgia rheumatica with normal inflammatory indices at the time of diagnosis: can we just move a step forward?诊断时炎症指标正常的风湿性多肌痛：我们能否更进一步？
Reumatologia. 2020;58(3):184-186. doi: 10.5114/reum.2020.96549. Epub 2020 Jun 29.
5
Frequency and distribution of various rheumatic disorders associated with checkpoint inhibitor therapy.与检查点抑制剂治疗相关的各种风湿性疾病的频率和分布。
Rheumatology (Oxford). 2019 Dec 1;58(Suppl 7):vii40-vii48. doi: 10.1093/rheumatology/kez297.
6
Autoimmunity associated with Erdheim-Chester disease improves with BRAF/MEK inhibitors.与 Erdheim-Chester 病相关的自身免疫性疾病在使用 BRAF/MEK 抑制剂后有所改善。
Haematologica. 2019 Nov;104(11):e502-e505. doi: 10.3324/haematol.2018.214007. Epub 2019 Mar 28.